Retrospective analysis evaluates safety and effectiveness of robot-assisted pyeloplasty in elderly patients, indicating similar outcomes to younger patients.
OBJECTIVE: To evaluate the safety, feasibility, and surgical outcomes of robot-assisted pyeloplasty (RAP) in elderly compared with non-elderly patients for ureteropelvic junction obstruction (UPJO). METHODS: This retrospective study included 83 consecutive patients undergoing RAP between January 2017 and August 2025. Patients were stratified into elderly (≥ 65 years, n = 14) and non-elderly (< 65 years, n = 69) groups. We compared patient backgrounds, perioperative outcomes (operative/anastomosis time, blood loss, and hospital stay), and postoperative complications graded by the Clavien-Dindo classification. Success was defined as symptom resolution and/or improved diuretic renogram flow 6-12 months postoperatively. RESULTS: Mean operative time (214 ± 19 vs. 207 ± 8 min, p = 0.75), anastomosis time (50 ± 4 vs. 43 ± 2 min, p = 0.11), and estimated blood loss (13 vs. 20 g, p = 0.33) showed no significant differences between the elderly and non-elderly groups. The total complication rate did not differ significantly between the two groups (p = 0.22). Surgical success rates were 93.8% in the elderly and 97.1% in the non-elderly group (p = 0.53) over a median 18-month follow-up. CONCLUSION: RAP is a safe and effective procedure for appropriately selected elderly patients with ureteropelvic junction obstruction, demonstrating perioperative outcomes and surgical success rates largely comparable with those in younger patients.
No takes yet. Share an insight, caveat, or question.
Mori et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: